Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. - sprookjes - yvandenbroek - TriplyDB

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.

http://www.wikidata.org/entity/Q34132964

about

To BRAF or not to BRAF: is that even a question anymore?Epilepsy related to developmental tumors and malformations of cortical development One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature MAPK pathway activation in pilocytic astrocytoma Will kinase inhibitors make it as glioblastoma drugs?Pathological and molecular advances in pediatric low-grade astrocytoma Somatic mutations in solid tumors: a spectrum at the service of diagnostic armamentarium or an indecipherable puzzle? The morphological eyes looking for BRAF and somatic molecular detections on cyto-histological samples BRAF V600E-mutated diffuse glioma in an adult patient: a case report and review.Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of cases.A neuropathology-based approach to epilepsy surgery in brain tumors and proposal for a new terminology use for long-term epilepsy-associated brain tumors.Pediatric low-grade gliomas: how modern biology reshapes the clinical field.BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications.Declining childhood and adolescent cancer mortality Diagnostic application of high resolution single nucleotide polymorphism array analysis for children with brain tumors Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1 Desmoplastic infantile ganglioglioma with late presentation. A clinical, radiological and histopathological analysis.Temporal lobe pleomorphic xanthoastrocytoma and acquired BRAF mutation in an adolescent with the constitutional 22q11.2 deletion syndrome.MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas.Chromosome band 7q34 deletions resulting in KIAA1549-BRAF and FAM131B-BRAF fusions in pediatric low-grade Gliomas.p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors.Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing.In search of targeted therapies for childhood cancer.Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas.MGMT Promoter Methylation and BRAF V600E Mutations Are Helpful Markers to Discriminate Pleomorphic Xanthoastrocytoma from Giant Cell Glioblastoma.Composite pleomorphic xanthoastrocytoma-epithelioid glioneuronal tumor with BRAF V600E mutation - report of three cases PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma.Epithelioid GBMs show a high percentage of BRAF V600E mutation.Massive dissemination from spinal cord gangliogliomas negative for BRAF V600E: report of two rare adult cases.Anaplastic PXA in adults: case series with clinicopathologic and molecular features BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants.Molecular profiling of childhood cancer: Biomarkers and novel therapies Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype.Molecular markers in pediatric neuro-oncology.Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion.MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2.Analysis of the BRAF(V600E) Mutation in Central Nervous System Tumors.Biomarker-based prognostic stratification of young adult glioblastoma

P2860

Q26829788-447C05E4-1725-40DF-BFD2-AC830453768B Q26829946-17D84127-9254-4E2C-ACC9-304F02EFA3D4 Q26863688-15AEDFA2-61ED-4598-87FA-F381786794CA Q27006028-A8A98D3C-DDD1-4341-99DA-40E2AF9A3A7E Q27012684-9E999056-16AD-49BE-A70B-735703EA8623 Q27026123-473C3E15-A993-4A5D-BB8C-61AE23DE36D1 Q28070226-8FA1D495-8FE6-4874-B0FE-61D1924993A4 Q31002780-29DF8190-5BEB-4210-A1A1-EB23F7CE5881 Q33631039-48C724DE-BD8B-446A-90F9-DB7E8A7DF634 Q33764533-CD73806F-5155-4250-9CE4-1BA403059D06 Q33847771-4C120556-DD82-403B-B87C-578597B7A741 Q33867475-297DED70-F238-443F-88AA-B399E929AF8A Q34060045-9E00C68E-8DBA-4686-95BD-165C498241E5 Q34166553-BB58745C-30E5-4CD9-A0E3-6B30BA1216CA Q34342166-7E6457B8-836A-455E-A50A-BD88E32C76FD Q34369775-22A12900-6370-433E-B48A-F94B40BDFA1F Q34388261-CAAFE9A6-4DC3-41F3-87B7-7C5CC79F2C4D Q34734398-F7F77E5F-AA54-49C3-AE2C-EB8698D80255 Q34810518-DDA600AE-98ED-42D2-B753-93647026AD58 Q35133362-454F0581-2C03-40FE-9E40-421E0D6AD0FA Q35449751-45EB5FF2-4204-46D3-A74C-7590E611726F Q35894536-C6D94539-F8A4-47B4-818A-0528C05A4FE5 Q35971733-6C6EA8FD-2628-469D-9F08-5D96D642225C Q36001219-8997176C-6896-43AB-8182-480CBC10AA6C Q36009738-549677ED-883A-4B48-89A4-C7EAC8ACB2E3 Q36010103-5C259F38-3E35-4F55-84B8-6E5CDE3933BC Q36037961-ED509405-3607-4E03-8000-45AE9DA45164 Q36124655-DBC3F7F6-5752-4586-9C4B-D814D24E87C5 Q36157714-09FD5EA9-2D1C-41C6-9C05-A3BC148EB2CE Q36175648-FD4B06DC-1AE5-4EB0-978C-11F4ABCE85DA Q36192363-448F815B-DB93-4894-84F5-427D560B5E58 Q36197602-9D262566-A37A-4174-8E2A-EACFF51DAB41 Q36239628-C6FF6861-8C56-47E9-9E29-F42A70C78D65 Q36250783-137E5C52-D314-4454-944F-B07EB39265F0 Q36288263-B0508831-D2A0-4CD0-BFC1-CF0A019DD5A2 Q36344704-0B11CD7D-37A8-4E4D-A052-D03B9C6DBEF6 Q36376520-32D02CA5-C922-4F2C-9D31-399342949BFF Q36500392-D44FF7FF-2FA5-4D80-92DA-4B426DD107DF Q36525778-344A3EB0-0CAF-4D10-A090-D9D925A8E94A Q36782664-7498A99D-D64F-4830-85CA-B399ECB66CFF

P2860

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.

http://www.wikidata.org/entity/Q34132964

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.

@ast

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.

@en

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.

@nl

type

label

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.

@ast

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.

@en

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.

@nl

prefLabel

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.

@ast

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.

@en

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.

@nl

P1433

Q34132964-20256F70-55CF-465F-A178-A9CEA5C068E0

P1476

Q34132964-8A9E0B6B-5968-4B8E-8B0D-FABAA6A986CD

P2093

Q34132964-150E7896-500C-404E-82AF-E0DBBB753A27

Q34132964-3DEBF018-4124-4843-A2B5-E7B24D5C14AB

Q34132964-3F9450A6-E0A0-4C4F-8BDA-1BCA68DC3167

Q34132964-63C6E199-93A2-4771-A647-34A54BFECB44

Q34132964-76609AFD-F2A1-487F-A417-9992DF2B9E84

Q34132964-857E0381-CD75-4282-9D23-9CF5B270DEF2

Q34132964-8B981850-B137-4D3A-B25B-78B5DB83ACC6

Q34132964-AA42B571-8A3D-4717-A7B9-940824A98EB4

P2860

Q34132964-03C3EE46-2734-4E0F-94B6-52BA0BEC990B

Q34132964-0CA01CDD-3BF1-482C-9DE2-14E8D32215C6

Q34132964-12F28C6A-C64F-4141-A18B-0E598A4182F8

Q34132964-15EBC95C-05E5-480D-8689-83EFD1761983

Q34132964-1C46CE7E-7F03-437B-89CC-3126D248E5CE

Q34132964-1C6738A1-5E6A-4574-A82C-B3E586F5940B

Q34132964-2427A232-CC20-413E-BDD3-E93EA29A84EE

Q34132964-27E6296C-E530-456A-9CEB-766C36699A30

Q34132964-2AF8F574-CBBA-4B86-8A0D-961350041FF6

Q34132964-2B4BD154-C0F3-464E-A1A4-2D3FFD985183

P304

Q34132964-68004448-51B4-4331-A945-AE211D13F3B6

P31

Q34132964-7DF26195-1A93-4E5F-AD42-94EF41EEF501

P356

Q34132964-1033A31E-9878-4507-AFAD-8B676B87FBFA

P433

Q34132964-93E3B9DA-74F7-4E67-A397-A320E7C9055B

P478

Q34132964-78B73878-8B84-45FE-AA64-B19F6AF0EDD5

P577

Q34132964-BDAF1BB8-5851-49D0-9BA7-6C1107618EC7

P5875

Q34132964-CC0B3432-A40C-4676-8ED2-4F657E2A066B

P698

Q34132964-32DC0F11-DB19-4384-9087-51BF7C0D5286

P932

Q34132964-5E2E139E-19A0-49E2-8C0E-DCAAB1DD1299

P356

P1433

P1476

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.

@en

P2093

Adam C Resnick

http://www.w3.org/2001/XMLSchema#string

Angela J Sievert

http://www.w3.org/2001/XMLSchema#string

Changqing Ma

http://www.w3.org/2001/XMLSchema#string

Jaclyn A Biegel

http://www.w3.org/2001/XMLSchema#string

Marcia S Brose

http://www.w3.org/2001/XMLSchema#string

Margaret J Dougherty

http://www.w3.org/2001/XMLSchema#string

Mariarita Santi

http://www.w3.org/2001/XMLSchema#string

Phillip B Storm

http://www.w3.org/2001/XMLSchema#string

P2860

MAP'ing CNS development and cognition: an ERKsome process

IDH1 and IDH2 mutations in gliomas

Mutations of the BRAF gene in human cancer

Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas

Mutational analysis of TSC1 and TSC2 genes in gangliogliomas.

Mixed dysembryoplastic neuroepithelial tumor and ganglioglioma.

Juvenile myelomonocytic leukemia and Noonan syndrome.

Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene.

The Raf/MEK/ERK pathway: new concepts of activation.

A review of the cytogenetics of 58 pediatric brain tumors.

P304

621-630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOQ007

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41435190

http://www.w3.org/2001/XMLSchema#string

P698

20156809

http://www.w3.org/2001/XMLSchema#string

P932

2940652

http://www.w3.org/2001/XMLSchema#string